Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Share Issue/Capital Change 2021

Aug 17, 2021

59255_rns_2021-08-17_a75608ed-31c7-4456-a84d-1c11358987ea.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [100 x 31] intentionally omitted <==

17[th] August, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)

Dear Sir/Madam,

This is to inform that the Company has allotted 10375 equity shares of face value of Re.1/‐ each in accordance with the terms of ESOP 2018, on 16[th] August, 2021.

Consequent to the said allotment the paid up share capital of the Company has gone up to 127601746 equity shares of face value of Re.1/‐ each aggregating to Rs. 12,76,01,746/‐.

Thanking You,

For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [83 x 34] intentionally omitted <==

Mr. Mandar Godbole GM Legal & Company Secretary (Membership No – 30240)

==> picture [426 x 57] intentionally omitted <==